Dublin, Ireland – February 20th, 2020 – Aalto Bio Reagents today announced the availability of its new recombinant SARS-CoV-2 nucleocapsid protein (code CK 6...

Aalto Bio sponsors 3rd intl congress on Zika and aedes related infections, Washington DC February 14th 2020